September 16, 2021
Amolyt Raises $80 Million to Advance Rare Endocrine Pipeline
Read More
September 16, 2021
Anjarium Raises $61 Million to Develop Next-Generation Non-viral Gene Therapies
Read More
September 15, 2021
Avalo Raises $27.5 Million to Advance Pipeline of Cancer and Rare Genetic Disease Therapies
Read More
September 14, 2021
Skyhawk Raises $133 Million to Advance its RNA-Modifying Candidates into the Clinic
Read More
September 14, 2021
Vanqua Bio Launches with $85 Million to Target Neurodegenerative Diseases
Read More
September 14, 2021
Walking Fish Launches with $50 Million to Advance B Cell Therapies for Multiple Diseases
Read More
September 9, 2021
Mammoth Raises $195 Million to Build Next-Generation CRISPR Therapeutics and Diagnostics
Read More
September 9, 2021
iECURE Launches With $50 Million to Develop In Vivo Gene Insertion
Read More
September 9, 2021
LEXEO Therapeutics Closes $100 Million to Advance Gene Therapy Pipeline
Read More
September 8, 2021
ADARx Raises $75 Million to Advance Pipeline of RNA Targeting Therapeutics
Read More
September 8, 2021
Attralus Raises $116 Million to Advance Pan-Amyloid Removal Therapeutics
Read More
September 8, 2021
Bluebird Bio Secures $75 Million Ahead of Separation into Two Companies
Read More
Load More
X